Etavopivat showed a 27% reduction in vaso-occlusive crisis events and ~4-month delay to first vaso-occlusive crisis event on ...

Novo Nordisk said April 23 it plans to seek expanded FDA approval for its Ozempic pill in the second half of 2026, which would make the drug the first oral GLP-1 approved for children and adolescents ...

April 23 () - Novo ‌Nordisk's ‌oral GLP-1 drug ​met the main goal ‌of ⁠a late-stage study ⁠in children ​and ​adolescents ...

FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo ...

Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug ...

Novo Nordisk A/S (NYSE:NVO) is included among the 10 Best Affordable Blue Chip Stocks to Buy Now. Novo Nordisk A/S (NYSE:NVO) ...

Bagsværd, Denmark, 14 April 2026 – Novo Nordisk today announced a strategic partnership with OpenAI that will place Novo Nordisk at the forefront of AI transformation in healthcare and help the ...

Novo Nordisk’s recent decline sparks valuation debate as fundamentals, earnings strength, and pharma positioning reshape ...

Hi, this is Charles in Stockholm. Welcome to our weekly newsletter on what’s shaping economies and investments from the Arctic to the Baltic Sea. You can subscribe here. While the Danish economy looks ...

PIONEER TEENS is the first clinical trial of an oral GLP-1 RA therapy in children and adolescents aged 10–17 years with type 2 diabetes, addressing a significant unmet need. The trial demonstrated a ...

Three years ago, Eli Lilly ( LLY 2.40%) and Novo Nordisk ( NVO +1.87%) had about the same market value. Given how well both ...

ALLEROD, Denmark, Jan 30 (Reuters) - A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk will premiere on Saturday at a theatre outside Copenhagen. "The Golden Calf" tells ...